Tuesday, 27 June 2017

Merck's cholesterol drug clears main goal in late-stage study

(Reuters) - Merck & Co Inc said on Tuesday its cholesterol drug met its main goal of reducing coronary heart diseases in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)